It’s also the most common type of lung cancer, making up 40% of all lung cancers. Squamous cell carcinoma is a subtype of NSCLC. Many people with this subtype of lung cancer have a history of ...

This week, archaeologists identified depictions of the Milky Way galaxy in ancient Egyptian imagery. A mathematician found a ...

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell carcinoma (LUSC) – which accounts for almost a third of all non-small cell ...

This includes the airways in your lungs. One clinical trial of Opdivo involved adults with squamous non-small cell lung cancer (NSCLC). Researchers found that people with squamous NSCLC who took ...

The antibody-drug conjugate (ADC) is currently under review by the FDA as a treatment for advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) in adults who have undergone prior ...

The trial evaluated the efficacy and safety of camrelizumab versus a placebo in combination with carboplatin and paclitaxel as first-line treatment of advanced squamous non-small cell lung cancer ...

The drug is already approved in the EU to treat certain cases of oesophageal squamous cell carcinoma (ESCC), gastric or gastroesophageal junction (G/GEJ) adenocarcinoma and non-small lung cancer. The ...

Medically reviewed by Marla Anderson, MDMedically reviewed by Marla Anderson, MD Non-small cell lung cancer (NSCLC ...